Company

Partnering

Why partner with us?

  • We offer an appropriate strategy and combination of approaches from a wide range of leading technologies
  • Our technologies are developed, enhanced and adapted to customer and market needs
  • We have solutions for projects on all levels of complexity: straightforward discovery to particularly challenging settings
  • Our strong abilities to characterize antibody candidates complement our various discovery options, bridging towards therapeutic development
We have proven our capabilities in multiple partnerships throughout the US and Europe and a number of antibodies from our discovery platform are currently in clinical development in various indications with high medical need.
PARTNERING

How we work

  • We select the ideal technology set for a project’s specific needs from unique suite of in vitro and in vivo approaches
  • We flexibly adapt to our partners’ needs
  • If desired, we can function as extended arm of the customer, fully integrating with internal project teams
  • We offer a variety of different business models and deal structures
Hands
PARTNERING

Some of Our Partners

We have proven our capabilities in multiple partnerships throughout the US and Europe and a number of antibodies from our discovery platform are currently in clinical development in various indications with high medical need.

 

45+
Collaborative
projects
Lilly Affimed Team Pierre fabre
Daiichi-Sankyo Bluebirdbio Molmed
LET’S CONNECT

Contact

Discover our solutions
tailored to your needs!

Our Services

Antibody
Discovery

Services

Antibody
Optimization

Services

Our Unique Platforms

Proprietary
Libraries

Technologies

Rabbit Mass
Humanization

Technologies

AbSieve®
Antibody
Selection

Technologies

AbAccel®
Antibody
Optimization

Technologies